Company:  ONCORUS, INC. (ONCR)
Form Type:  8-K
Filing Date:  6/23/2022 
CIK:  0001671818 
Address:  50 HAMPSHIRE STREET
SUITE 401
 
City, State, Zip:  CAMBRIDGE, Massachusetts 02139 
Telephone:  857-320-6400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.35  
Change: 
0.01 (0.75%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$34.94M
Trade ONCR now with 

© 2022  
Description of Business
We are a clinical-stage biopharmaceutical company focused on developing next-generation, systemically active viral immunotherapies to transform outcomes for cancer patients. Using our two proprietary platforms, we are developing a pipeline of intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and deliver transgenes to stimulate multiple arms of the immune system against tumors. We believe the therapies that we are developing will bring significant benefit to many patients who are currently underserved by approved immuno-oncology therapies, including other viral immunotherapies and immune checkpoint inhibitors.
Register and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.02 Departure of Directors or Certain Officers; ...
      Item 5.07 Submission of Matters to a Vote of Security Holders.
    SECTION 7 REGULATION FD
      Item 7.01 Regulation FD Disclosure.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 99.1